Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
about
Glutamatergic autoencephalitides: an emerging fieldIn Rasmussen encephalitis, hemichannels associated with microglial activation are linked to cortical pyramidal neuron coupling: a possible mechanism for cellular hyperexcitabilityIon channels in genetic and acquired forms of epilepsy.Progress in autoimmune epileptic encephalitisRasmussen's encephalitis: clinical features, pathobiology, and treatment advances.Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.Autoimmune-mediated encephalitis.Diagnostic and pathogenic significance of glutamate receptor autoantibodies.Autoimmune channelopathies: new antibody-mediated disorders of the central nervous systemRasmussen encephalitis and comorbid autoimmune diseases: A window into disease mechanism?Autoimmune encephalitis and its relation to infection.CD8(+) T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing.Autoantibody-mediated disorders of the central nervous system.Reactions of the immune system in epilepsyEvidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis.Epileptogenesis and rational therapeutic strategies.Autoimmune channelopathies.Differential expression of interferon-γ and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune responseAutoantibodies and neurodegeneration in multiple sclerosis.Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis.Therapeutic apheresis in neurological disorders: a survey of the evidence in support of current category I and II indications for therapeutic plasma exchange.Encephalitis and epilepsy.Eponym : Rasmussen syndrome.The role of inflammation in epilepsyPathogenic and physiological autoantibodies in the central nervous system.Immune mechanisms in epileptogenesis.Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepImmunity and Inflammation in Epilepsy.Pediatric Autoimmune Epileptic Encephalopathies.The Diverse Roles of Microglia in the Neurodegenerative Aspects of Central Nervous System (CNS) Autoimmunity.Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.A case of Rasmussen encephalitis treated with rituximab.A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFalpha, and Granzyme B in CSF.Antiglial cell autoantibodies and childhood epilepsy: a case report.Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels.Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis.Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.
P2860
Q26992294-BC86E7DF-FEDA-4791-AC98-EB6145A8A0F8Q27313889-D003DEBC-18D7-47C1-8051-E2F3F2C7B86BQ27693827-4B424241-763C-44EA-800B-D1FD357F1E3FQ28077159-CA1C5EED-189B-4B0B-A76F-C9A14D7FD37DQ30741122-0E32FF37-4952-45F7-BA12-374A207C2EB2Q33770508-A89C2EC8-4557-4EF9-87CE-73F50EAF773EQ33805014-0E769338-B586-44C6-8458-351509430BB5Q33969433-B5CDFE66-9897-4D40-965F-770A39E89770Q34167246-A962ED4E-4F8C-4895-B8CB-C5D2026E5B1EQ34198746-0898E887-6882-47FA-B9D4-0794B9AF7DD4Q34460643-B994BED0-009D-44E3-9B27-D09FEB3910F7Q34520675-ECD1B6B1-DC80-49D2-AC99-AC53054F857DQ34733326-77E571E7-EEA8-41D1-AF85-7029FF966605Q35224998-72A414B4-2ADD-4B77-9F45-3366901B6C3CQ35863667-8C94D60C-26CF-430D-9D33-AF36314B14E4Q36379406-928A5D61-E436-4604-A103-4A446DF821C3Q36577209-146E02AE-8378-4380-8814-2E26D6CEB73EQ36854093-A16317D4-B92B-48CD-918B-44A8A82EB60CQ37180839-2D6EADA9-7F0A-4058-8E25-CCE01CBF3C0EQ37203376-B3D257CA-9D96-4812-8A85-B1C555300133Q37313353-D5388945-1A3E-46F7-804D-BB9AD388B94FQ37599545-69E042BC-A2CA-4BB4-BFA7-B57300D31937Q37696997-F6845BFD-87D3-494D-8C2F-E20B2AD0CE05Q37816957-E53BDA8A-4FD5-4158-AB6F-F27E82F246FCQ38020957-5C55A986-D3A7-4745-A431-C66BDBA433A1Q38165168-65476B08-E0D4-4C08-8615-87C2878346BCQ38235715-41215DDE-BE17-4252-BAD1-256C868CFFBFQ38673807-3D601E1C-7278-439B-B5C6-494CAE37B87EQ39068563-04ED3688-F897-4287-85CA-85C6D0C538B6Q39154769-6FBBC9F1-9940-42A0-8508-2B608454D1D1Q39180685-20F6360B-AC19-4070-B9E9-53D6103AADB4Q43298052-3D800D3F-942B-44A9-9983-87C98C47D683Q45845288-7FDD2F79-A107-47AC-879D-8557B4386D69Q46629517-31985B93-EE0F-453B-8C67-C136A1BC5229Q50645025-D6E20304-C380-4D72-8C2A-6C8065CB6F73Q52720739-9415638D-76CB-45D9-AFBB-438AC21C5C0FQ52726071-A52DE1E7-76C4-40F4-8BE2-6EDC5CBBFFCB
P2860
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
@ast
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
@en
Absence of antibodies to glutamate receptor type 3
@nl
type
label
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
@ast
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
@en
Absence of antibodies to glutamate receptor type 3
@nl
prefLabel
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
@ast
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
@en
Absence of antibodies to glutamate receptor type 3
@nl
P2093
P1433
P1476
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
@en
P2093
A Roubertie
K McKnight
P356
10.1212/01.WNL.0000132651.66689.0F
P407
P577
2004-07-01T00:00:00Z